ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

PRTC PureTech Health PLC

28,74
-1,06 (-3,56%)
Última atualização: 11:48:41
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
PureTech Health PLC PRTC NASDAQ Recibo de Depósito
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-1,06 -3,56% 28,74 11:48:41
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
28,74 28,40 28,74 29,80
mais cotações »

Notícias Recentes

Data Hora Fonte Título
13/06/202414:15BWPureTech Health: Results of Annual General Meeting
06/06/202413:38BWPureTech Health: Result of General Meeting
29/05/202409:09BWPureTech Founded Entity Akili Interactive and Virtual..
23/05/202408:00BWPureTech to Present at the Jefferies Global Healthcare..
21/05/202408:05BWPureTech Founded Entity Vedanta Biosciences Enrolls First..
20/05/202403:00BWPureTech Health: Launch of Proposed $100 Million Tender..
09/05/202408:05BWPureTech Founded Entity Seaport Therapeutics Presents Data..
07/05/202408:05BWPureTech Founded Entity Seaport Therapeutics Adds Industry..
25/04/202406:22BWPureTech Announces Annual Results for Year Ended December..
18/04/202403:00BWPureTech Health: Notice of Results
16/04/202408:00BWPureTech Announces Completion of Enrollment in Phase 2b..
11/04/202408:00BWPureTech Receives FDA Fast Track Designation for LYT-200 in..
09/04/202403:00BWPureTech Launches Seaport Therapeutics with $100 Million..
19/03/202404:00BWPureTech Proposes $100 Million Capital Return
18/03/202410:52BWBristol Myers Squibb Completes Acquisition of PureTech's..
13/03/202408:00BWPureTech Receives Orphan Drug Designation for LYT-200 in..
27/02/202409:00BWPureTech to Present at Two Upcoming Investor Conferences
27/02/202404:00BWPureTech Founded Entity Akili Announces Positive Results..
03/01/202409:00BWPureTech to Present at 42nd Annual J.P. Morgan Healthcare..
22/12/202311:13BWPureTech Founded Entity Karuna Therapeutics to be Acquired..
20/12/202304:00BWPureTech Year End Update and Outlook for 2024
07/12/202308:00BWPureTech Presents Data from Phase 1 Trial of LYT-200..
29/11/202312:17BWPureTech Founded Entity Karuna Therapeutics Announces U.S...
17/11/202304:00BWPureTech Founded Entity Karuna Therapeutics Announces..
14/11/202304:00BWPureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary..
17/10/202303:00BWPureTech to Present at Two Upcoming Investor Conferences
11/10/202308:00BWPureTech Presents Data from LYT-100 (Deupirfenidone) Trial..
04/10/202308:05BWPureTech Founded Entity Vedanta Biosciences Announces First..
28/09/202308:38BWKarXT, invented at PureTech, submitted for FDA Approval in..
27/09/202303:05BWPureTech Announces the Appointment of Robert Lyne as Chief..
29/08/202303:00BWPureTech Health plc – Half-Year Report
22/08/202303:00BWPureTech Health: Notice of Half-Yearly Results
01/08/202308:00BWPureTech Awarded up to $11.4 Million from U.S. Department of..
21/06/202308:00BWPureTech Initiates Phase 2a Clinical Trial of LYT-300 (Oral..

Seu Histórico Recente

Delayed Upgrade Clock